-+ 0.00%
-+ 0.00%
-+ 0.00%

SHARES OF BIOGEN UP 5% AFTER US FDA APPROVES SUBCUTANEOUS STARTING DOSE FOR ALZHEIMER'S DRUG LEQEMBI

Reuters·07/13/2026 18:15:20

Please log in to view news